Comparing the original and biosimilar biotherapeutics of the monoclonal antibody eculizumab by intact mass measurement and middle-up mass spectrometry analysis
Objectives. In this biosimilar research, we compare the monoclonal antibody eculizumab obtained from different drugs [original Soliris® (Alexion Pharmaceuticals) and candidate Elizaria® (Generium)] by intact mass measurement and middle-up mass spectrometry analysis to enhance the role of mass spectr...
Saved in:
| Main Authors: | M. B. Degterev, R. R. Shukurov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
MIREA - Russian Technological University
2021-03-01
|
| Series: | Тонкие химические технологии |
| Subjects: | |
| Online Access: | https://www.finechem-mirea.ru/jour/article/view/1688 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterization of intact mRNA-based therapeutics by charge detection mass spectrometry and mass photometry
by: Evolène Deslignière, et al.
Published: (2025-06-01) -
Quantification of Staphylococcal Enterotoxin A Variants at Low Level in Dairy Products by High-Resolution Top-Down Mass Spectrometry
by: Nina Aveilla, et al.
Published: (2024-12-01) -
Acoustic ejection mass spectrometry: An integrated pipeline for ultra-high throughput screening, reactivity profiling, and potency analysis of covalent BTK inhibitors
by: Ronghai Cheng, et al.
Published: (2025-08-01) -
Evaluation of the impact of antibody fragments on aggregation of intact molecules via size exclusion chromatography coupled with native mass spectrometry
by: Jing Xu, et al.
Published: (2024-12-01) -
High-Performance Data Acquisition for Fourier Transform Mass Spectrometry
by: Anton N. Kozhinov, et al.
Published: (2025-02-01)